THE SEROTONIN HYPOTHESIS OF
SCHIZOPHRENIA
The discovery that
indole hallucinogens such as LSD (lysergic acid diethylamide) and mescaline are
serotonin (5-HT) agonists led to the search for endogenous hallucinogens in the
urine, blood, and brains of patients with schizophrenia. This proved fruitless,
but the identification of many 5-HT-receptor subtypes led to the piv-otal
discovery that 5-HT2A-receptor and possibly 5-HT2C stimula-tion was the basis for the
hallucinatory effects of these agents.
It has been found that
5-HT2A-receptor blockade is
a key factor in the mechanism of action of the main class of atypical
antipsychotic drugs, of which clozapine is the prototype, and includes, in
order of their introduction around the world, melperone, risperidone, zotepine,
blonanseine olanzapine, quetiapine, ziprasidone, aripiprazole, sertindole,
paliperidone, iloperidone, asenapine, and lurasidone. These drugs are inverseagonists of the 5-HT2Areceptor; that is,
they block the consti-tutive activity of these receptors. These receptors
modulate the release of dopamine, norepinephrine, glutamate, GABA and
acetylcholine, among other neurotransmiters in the cortex, limbic region, and
striatum. Stimulation of 5-HT2A receptors leads to depolarization of glutamate neurons, but
also stabiliza-tion of N-methyl-D-aspartate (NMDA)
receptors on postsyn-aptic neurons. Recently, it has been found that
hallucinogens can modulate the stability of a complex consisting of 5-HT2A and NMDA receptors.
5-HT2C-receptor stimulation
provides a further means of modulating cortical and limbic dopaminergic
activity. Stimulation of 5-HT2C receptors leads to inhibition of cortical and limbic dop-amine
release. Many atypical antipsychotic drugs, eg, clozapine, asenapine,
olanzapine are 5-HT2C inverse agonists. 5-HT2C agonists are currently being studied as
antipsychotic agents.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2024 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.